<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0026">
 <label>26</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Haider</surname>
    <given-names>K</given-names>
   </string-name>, 
   <string-name>
    <surname>Rahaman</surname>
    <given-names>S</given-names>
   </string-name>, 
   <string-name>
    <surname>Yar</surname>
    <given-names>MS</given-names>
   </string-name>, 
   <string-name>
    <surname>Kamal</surname>
    <given-names>A.</given-names>
   </string-name>
  </person-group>
  <article-title>Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)</article-title>. 
  <source>Expert Opin Ther Pat</source>
  <year>2019</year>;
  <volume>29</volume>:
  <fpage>623</fpage>â€“
  <lpage>41</lpage>.
  <pub-id pub-id-type="pmid">31353978</pub-id>
 </mixed-citation>
</ref>
